Symbol Lookup
ABBOTT LABORATORIES Add to My Watchlist (NYSE: ABT) 

     ABBOTT 54.07 +0.46 (+0.86%) 6,268,773
Profile for ABT
ABBOTT LABORATORIES
100 Abbott Park Road
Abbott Park, IL 60064-6400
http://www.abbott.com

Abbott Laboratories is principally engaged in the discovery, development, manufacture and sale of a variety of health care products through four business segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. Co.'s primary products are prescription pharmaceuticals, nutritional products, vascular products and diagnostic testing products. In addition, Co. has a 50.0%-owned joint-venture, TAP Pharmaceutical Products Inc. with Takeda Pharmaceutical Company Ltd. of Japan, through which Co. develops, markets and sells pharmaceutical products such as Lupron , Lupron Depot and Prevacid (lansoprazole), within the U.S., Puerto Rico and Canada.
Headquarters for ABT
Key Facts
Industry Health
Sector Pharmaceuticals
# of Employees 66,663
Shares Outstanding 1.5B
Market Cap 83.6B
Enterprise Value 64.9B
52-Week High $57.39
52-Week Low $41.27
P/E Ratio 15.06
EPS $3.59/shr
Dividend $1.60/shr
Yield 2.96%
Key Executives
Mr. Miles D. White Chief Executive Officer; Chairman
Mr. Thomas C. Freyman Chief Financial Officer; Executive Vice President
Mr. Greg W. Linder Controller; Vice President
Mr. John M. Capek Division Officer
Mr. Joseph M. Nemmers Jr. Division Officer
Mr. Richard W. Ashley Executive Vice President
Mr. Holger Liepmann Executive Vice President
Ms. Laura J. Schumacher Executive Vice President; Secretary; General Counsel
Mr. Jeffrey R. Binder Senior Vice President
Mr. Olivier Bohuon Senior Vice President
Mr. Thomas F. Chen Senior Vice President
Mr. Stephen R. Fussell Senior Vice President
Mr. Robert B. Hance Senior Vice President
Mr. John C. Landgraf Senior Vice President
Mr. Gary E. McCullough Senior Vice President
Mr. James L. Tyree Senior Vice President
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock Updates provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs
E-mail Article to a Friend